Nektar Therapeutics (NKTR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

4.8700

-0.0100

(-0.20%)

At close: 04:00PM EDT

4.8700

0.00

(0.00%)

After hours:

04:32PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	4.8800
Open	4.5700
Bid	4.7500 x 2200
Ask	4.8800 x 3200
Day's Range	4.6000 - 4.9450
52 Week Range	3.0200 - 19.3700
Volume	3,693,001
Avg. Volume	3,343,661

Market Cap	912.662M
Beta (5Y Monthly)	1.17
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NKTR

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Nektar Therapeutics
NKTR: What does Argus have to say about NKTR?NEKTAR THERAPEUTICS has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.
Rating
Fair Value
Economic Moat
last monthArgus Research